Different Tissue Distribution of Paclitaxel With Intravenous and Intraperitoneal Administration

Journal of Surgical Research

Volumn 155, Issue 1, 2009, Pages 142-146

  Soma, Daisuke ^a   Kitayama, Joji ^a   Ishigami, Hironori ^a   Kaisaki, Shoichi ^a   Nagawa, Hirokazu ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

Author keywords

intraperitoneal chemotherapy; paclitaxel; tissue distribution

Indexed keywords

PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; FEMALE; MESENTERY LYMPH NODE; NONHUMAN; OMENTUM; OVARY; PRIORITY JOURNAL; RABBIT; STOMACH; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; FEMALE; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; PACLITAXEL; RABBITS; TISSUE DISTRIBUTION;

EID: 67349120696     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.06.049     Document Type: Article

References (31)

1. Wani M.C., Taylor H.L., Wall M.E., et al. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93 (1971) 2325
2. Rowinsky E.K., Cazenave L.A., and Donehower R.C. Taxol: A novel investigational antimicrotubule agent. J Natl Cancer Inst 82 (1990) 1247
3. Holmes F.A., Walters R.S., Theriault R.L., et al. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83 (1991) 1797
4. Einzig A.I., Wiernik P.H., Sasloff J., et al. Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma. J Clin Oncol 10 (1992) 1748
5. Chang A.Y., Kim K., Glick J., et al. Phase II study of taxol, merbarone, and piroxantrone in Stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results. J Natl Cancer Inst 85 (1993) 388
6. Forastiere A.A., Shank D., Neuberg D., et al. Final report of a Phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group trial (PA390). Cancer 82 (1998) 2270
7. Ajani J.A., Fairweather J., Dumas P., et al. Phase II study of taxol in patients with advanced gastric carcinoma. Cancer J Sci Am 4 (1998) 269
8. Armstrong D.K., Bundy B., Wenzel L., et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354 (2006) 34
9. Markman M., Bundy B.N., Alberts D.S., et al. Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume Stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol 19 (2001) 1001
10. de Bree E., Rosing H., Michalakis J., et al. Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination. Eur J Surg Oncol 32 (2006) 666
11. Yen M.S., Juang C.M., Lai C.R., et al. Intraperitoneal cisplatin-based chemotherapy versus intravenous cisplatin-based chemotherapy for Stage III optimally cytoreduced epithelial ovarian cancer. Int J Gynaecol Obstet 72 (2001) 55
12. Polyzos A., Tsavaris N., Kosmas C., et al. A Comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for Stage III ovarian cancer. Oncology 56 (1999) 291
13. Fushida S., Furui N., Kinami S., et al. Pharmacologic study of intraperitoneal paclitaxel in gastric cancer patients with peritoneal dissemination. Gan To Kagaku Ryoho 29 (2002) 2164
14. Fushida S., Nao F., Kinami S., et al. Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination. Gan To Kagaku Ryoho 29 (2002) 1759
15. Eiseman J.L., Eddington N.D., Leslie J., et al. Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice. Cancer Chemother Pharmacol 34 (1994) 465
16. Innocenti F., Danesi R., Di Paolo A., et al. Plasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice. Drug Metab Dispos 23 (1995) 713
17. Yonemura Y., Endou Y., Bando E., et al. Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer. Cancer Lett 210 (2004) 189
18. Mohamed F., Marchettini P., Stuart O.A., et al. A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery. Eur J Surg Oncol 29 (2003) 261
19. Furui N., Yamazaki M., Yokogawa K., et al. Ascites and the plasma concentration-time courses of the taxanes antitumor agents taxanes after an intraperitoneal administration in patients with peritoneal tumors. Jpn J Pharm Health Care Sci 29 (2003) 263
20. Francis P, Rowinsky E, Schneider J, et al. Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: A Gynecologic Oncology Group pilot Study. J Clin Oncol 1995;13:2961
21. Los G., Mutsaers P.H., van der Vijgh W.J., et al. Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: A comparison with systemic chemotherapy. Cancer Res 49 (1989) 3380
22. Flessner M.F., Fenstermacher J.D., Dedrick R.L., et al. A distributed model of peritoneal-plasma transport: Tissue concentration gradients. Am J Physiol 248 (1985) F425
23. Los G., Mutsaers P.H., Lenglet W.J., et al. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment. Cancer Chemother Pharmacol 25 (1990) 389
24. Knemeyer I., Wientjes M.G., and Au J.L. Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment. Cancer Chemother Pharmacol 44 (1999) 241
25. Kuh H.J., Jang S.H., Wientjes M.G., et al. Determinants of paclitaxel penetration and accumulation in human solid tumor. J Pharmacol Exp Ther 290 (1999) 871
26. Kyle A.H., Huxham L.A., Yeoman D.M., et al. Limited tissue penetration of taxanes: A mechanism for resistance in solid tumors. Clin Cancer Res 13 (2007) 2804
27. Lee S.H., Yoo S.D., and Lee K.H. Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 724 (1999) 357
28. Tabata K., Yamaoka K., Kaibara A., et al. Moment analysis program available on Microsoft Excel. Xenobiol Metab Dispos 14 (1999) 286
29. Peters J.H., Gordon G.R., Kashiwase D., et al. Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicin. Cancer Chemother Pharmacol 7 (1981) 65
30. Hatae M. The evaluation of the intraperitoneal chemotherapy. Oncol Chemother 15 (1999) 159
31. Levine S. Postinflammatory increase of absorption from peritoneal cavity into lymph nodes: Particulate and oily inocula. Exp Mol Pathol 43 (1985) 124